PFIZER SEEKS EXCLUSIVITY FOR ZOLOFT THROUGH 2005: ROLL CALL OF REQUESTS FOR PATENT EXTENSIONS BASED ON LENGTHY FDA REGULATORY REVIEW PERIODS